We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

180 hedge funds and large institutions have $1.87B invested in Spectrum Pharmaceuticals Inc in 2018 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 73 increasing their positions, 41 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 17

94% more call options, than puts

Call options by funds: $20.1M | Put options by funds: $10.4M

78% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 41

42% more capital invested

Capital invested by funds: $1.32B → $1.87B (+$554M)

12% more funds holding

Funds holding: 161 → 180 (+19)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
180
Holders Change
+19
Holders Change %
+11.8%
% of All Funds
4.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
37
Increased
73
Reduced
41
Closed
17
Calls
$20.1M
Puts
$10.4M
Net Calls
+$9.7M
Net Calls Change
+$15.4M

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$63.4M
2
Primecap Management
Primecap Management
California
+$50.1M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$31.6M
4
BlackRock
BlackRock
New York
+$27.1M
5
Citadel Advisors
Citadel Advisors
Florida
+$22.3M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$38.2M
2
Goldman Sachs
Goldman Sachs
New York
-$25.6M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$24.1M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$24.1M
5
Barclays
Barclays
United Kingdom
-$17.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$346M +$27.1M +1,463,249 +10%
Vanguard Group
2
Vanguard Group
Pennsylvania
$215M +$31.6M +1,703,989 +20%
Primecap Management
3
Primecap Management
California
$212M +$50.1M +2,706,000 +36%
CCM
4
Consonance Capital Management
New York
$146M +$14.1M +760,400 +12%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$127M -$24.1M -1,298,589 -18%
State Street
6
State Street
Massachusetts
$111M +$7.38M +398,494 +8%
Renaissance Technologies
7
Renaissance Technologies
New York
$73.7M -$38.2M -2,062,600 -37%
ACA
8
Avoro Capital Advisors
New York
$71.7M +$63.4M +3,419,818 New
Northern Trust
9
Northern Trust
Illinois
$26.5M +$3.44M +185,849 +17%
Citadel Advisors
10
Citadel Advisors
Florida
$26.5M +$22.3M +1,206,063 +2,116%
CAM
11
Cormorant Asset Management
Massachusetts
$25.2M +$22.2M +1,200,000 New
Norges Bank
12
Norges Bank
Norway
$24.3M +$979K +52,826 +5%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$23.5M -$24.1M -1,298,911 -54%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$23.2M +$631K +34,070 +3%
Wells Fargo
15
Wells Fargo
California
$22.7M +$999K +53,948 +5%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$20.3M +$2.59M +139,893 +17%
VOYA Investment Management
17
VOYA Investment Management
Georgia
$19.4M +$16M +862,647 +1,336%
Macquarie Group
18
Macquarie Group
Australia
$18M +$7.63M +411,938 +93%
Principal Financial Group
19
Principal Financial Group
Iowa
$15.9M +$698K +37,667 +5%
Invesco
20
Invesco
Georgia
$15.8M -$8.71M -470,118 -38%
TA
21
Teachers Advisors
New York
$14.6M +$998K +53,879 +8%
JGC
22
J. Goldman & Co
New York
$14.6M +$4.11M +221,902 +47%
AQR Capital Management
23
AQR Capital Management
Connecticut
$12.9M -$3.2M -172,517 -22%
PAM
24
Panagora Asset Management
Massachusetts
$12.8M +$257K +13,862 +2%
Charles Schwab
25
Charles Schwab
California
$11.9M +$1.61M +87,075 +18%
1
2 3 4 5

SPPI Hedge Fund Activity: Q2 2018 in Review

180 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2018, worth a combined $1.87B — up 42% from $1.32B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new SPPI positions and 17 closed out — a net gain of 20 holders — while 73 added to existing stakes and 41 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $63.4M. The largest seller was Renaissance Technologies, cutting an estimated $38.2M.

  • 180 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2018, up from 161 in Q1 2018.
  • Funds reported $1.87B of Spectrum Pharmaceuticals Inc stock for Q2 2018, up 42% quarter-over-quarter.
  • 37 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2018 and 17 closed out, a net change of +20 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q2 2018 was Avoro Capital Advisors, an estimated $63.4M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q2 2018 was Renaissance Technologies, an estimated $38.2M sold.

Based on aggregated 13F filings for Q2 2018.